{"version":"1.0","type":"link","title":"Seviteronel - Newikis","description":"Seviteronel (developmental codes VT-464 and, formerly, INO-464) is an experimental cancer medication which is under development by Viamet Pharmaceuticals and Innocrin Pharmaceuticals for the treatment of prostate cancer and breast cancer. It is a nonsteroidal CYP17A1 inhibitor and works by…","provider_name":"Newikis","provider_url":"https://newikis.com","cache_age":86400,"thumbnail_url":"https://thumb.wikimedia.org/wikipedia/commons/thumb/d/d8/VT-464.svg/1280px-VT-464.svg.png","thumbnail_width":1280,"thumbnail_height":815}